NYC Healthcare News



Noscira receives FDA approval for Tideglusib drug to treat PSP

November 08, 2015

Further highlights were the presentation of the ECNP Neuropsychopharmacology Award to Kaj Blennow, Sweden, for his pioneering research into Alzheimer-s disease; and the ECNP Lifetime Achievement Award to Moussa B. H. Youdim, Israel, for his innovative and lasting contribution to the field of neurodegenerative diseases and neuropsychiatric drug development.

The 23rd ECNP Congress 2010 in Amsterdam marked ECNP's ongoing commitment to alleviating the burden and suffering associated with mental disorders and disorders of the brain in general and maintaining Europe's outstanding tradition of neuropsychopharmacological science.

Source: European College of Neuropsychopharmacology